Appili Therapeutics Inc. (APLIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0140
0.00 (0.00%)
Jul 11, 2025, 4:00 PM EDT
Appili Therapeutics Employees
Appili Therapeutics had 7 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$9,983
Profits / Employee
-$260,866
Market Cap
1.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
Appili Therapeutics News
- 17 days ago - Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results - GlobeNewsWire
- 6 weeks ago - Appili Therapeutics Announces Formal Termination of Arrangement Agreement with Aditxt Inc. - GlobeNewsWire
- 7 weeks ago - Aditxt to terminate arrangement agreement with Appili Therapeutics - Seeking Alpha
- 7 weeks ago - Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc. - GlobeNewsWire
- 2 months ago - Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia - GlobeNewsWire
- 2 months ago - Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ®™ - GlobeNewsWire
- 3 months ago - Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025 - GlobeNewsWire
- 4 months ago - Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update - GlobeNewsWire